Insider Trading & Ownership - Mayer Arie

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mayer Arie
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-03
Purchase
2023-04-04
5:10 pm
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
8,809$2.2157$19,51826,809
(Direct)
View
2021-11-01
Sale
2022-05-10
5:30 pm
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
3,000$25.6$76,8000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-04
Option Award
2024-01-08
4:34 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
39,325$096,134
(Direct)
View
2023-04-17
Option Award
2023-04-20
06:00 am
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
30,000$056,809
(Direct)
View
2022-07-28
Option Award
2022-08-01
8:01 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
12,000$018,000
(Direct)
View
2022-01-03
Option Award(A)
2022-05-10
5:32 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
6,000$06,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
8:51 pm
N/A
2032-01-03
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
16,000$019,000
(Direct)
View
2020-01-08
Option Award
2020-01-14
4:06 pm
N/A
2030-01-08
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
20,000$020,000
(Direct)
View

Ownership
2019-12-11
4:53 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPMayer Arie
Director
0$03,000
(Direct)
View
(A) Indicate amendment filing.